U.S. Self-injection Devices Market Size & Outlook
U.S. self-injection devices market, 2018-2030 (US$M)
Related Markets
U.S. self-injection devices market highlights
- The U.S. self-injection devices market generated a revenue of USD 2,626.9 million in 2022 and is expected to reach USD 4,048.3 million by 2030.
- The U.S. market is expected to grow at a CAGR of 5.6% from 2023 to 2030.
- In terms of segment, needle-free injectors was the largest revenue generating product in 2022.
- Auto injectors is the most lucrative product segment registering the fastest growth during the forecast period.
Self-injection devices market data book summary
| Market revenue in 2022 | USD 2,626.9 million |
| Market revenue in 2030 | USD 4,048.3 million |
| Growth rate | 5.6% (CAGR from 2022 to 2030) |
| Largest segment | Needle-free injectors |
| Fastest growing segment | Auto injectors |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Needle-free injectors, Wearable injectors, Pen injectors, Auto injectors |
| Key market players worldwide | Ypsomed Holding AG, BD, Gerresheimer AG ADR, Antares Vision SpA, NuGen Medical Devices Inc, Pfizer Inc, Amgen Inc, Sulzer AG, Owen Mumford, SHL Medical |
Other key industry trends
- In terms of revenue, U.S. accounted for 37.8% of the global self-injection devices market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. self-injection devices market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 539.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Self-injection Devices Market Scope
Self-injection Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. self-injection devices market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to self-injection devices market will help companies and investors design strategic landscapes.
Needle-free injectors was the largest segment with a revenue share of 27.88% in 2023. Horizon Databook has segmented the U.S. self-injection devices market based on needle-free injectors, wearable injectors, pen injectors, auto injectors covering the revenue growth of each sub-segment from 2018 to 2030.
- U.S. Self-injection Devices Product Outlook (Revenue, USD Million, 2018-2030)
- Auto Injectors
- Fillable
- Prefilled
- Pen Injectors
- Single-chamber
- Dual-chamber
- Wearable Injectors
- On-body
- Off-body
- Needle-free Injectors
- Fillable
- Prefilled
- Auto Injectors
- U.S. Self-injection Devices Application Outlook (Revenue, USD Million, 2018-2030)
- Cancer
- Autoimmune Disorders
- Hormonal Disorders
- Pain Management
- Others
- U.S. Self-injection Devices End Use Outlook (Revenue, USD Million, 2018-2030)
- Hospitals & Clinics
- Home Care Settings
- Ambulatory Surgical Centers
- Others
Reasons to subscribe to U.S. self-injection devices market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. self-injection devices market databook
-
Our clientele includes a mix of self-injection devices market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. self-injection devices market , including forecasts for subscribers. This country databook contains high-level insights into U.S. self-injection devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. self-injection devices market size, by product, 2018-2030 (US$M)
U.S. Self-injection Devices Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
